SEBI Reg. Investment Advisor

Download App

Help Center Subscribe

Recent:

Top Pharma Companies in India by Market Cap

BSE Sensex 77763.91
261.79 (0.34%)

Filter

Top Pharma Companies in India as on Jul-2026 | 5 Star Rated Stocks Undervalued Stocks Fair Valued Stocks Uptrend Stocks

Filter

	Company Name	DeciZen	Market cap (Rs. Cr.)	CMP (Change %)	Latest P/E	Latest P/BV	5Y Sales Gr.(%)	5Y Profit Gr.(%)
61	Laxmi Dental Ltd.	Q V PT	1,236 Small Cap	228.10 (1.45%)	75.23	5	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
62	Shree Ganesh Remedies Ltd.	Q V PT	825 Small Cap	673.90 (4.90%)	46.4	5.06	13.20	20.49	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
63	Yatharth Hospital & Trauma Care Services Ltd.	Q V PT	8,313 Small Cap	865.40 (0.30%)	87.13	5.13	27.90	137.67	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
64	Eris Lifesciences Ltd.	Q V PT	20,056 Small Cap	1,432 (-1.05%)	32.37	5.14	21.92	3.58	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
65	Suven Life Sciences Ltd.	Q V+ PT	7,884 Small Cap	327.55 (9.68%)	N/A	5.24	-14.30	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
66	Sun Pharmaceutical Industries Ltd.	Q V+ PT	4,49,048 Large Cap	1,904.65 (1.77%)	39.12	5.37	9.87	23.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
67	Caplin Point Laboratories Ltd.	Q V PT	19,362 Small Cap	2,535.35 (-0.47%)	30.19	5.4	17.55	21.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
68	Ipca Laboratories Ltd.	Q V+ PT	43,597 Mid Cap	1,780.90 (3.64%)	38.5	5.46	8.87	4.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
69	Suraksha Diagnostic Ltd.	Q V PT	1,413 Small Cap	273.60 (0.85%)	43.9	5.77	9.86	-51.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
70	Poly Medicure Ltd.	Q V PT	17,614 Small Cap	1,680.05 (-3.32%)	52.43	5.77	19.91	26.50	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
71	Sun Pharma Advanced Research Company Ltd.	Q V+ PT	7,759 Small Cap	239.15 (0.02%)	5	5.82	-1.35	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
72	Vimta Labs Ltd.	Q V+ PT	2,619 Small Cap	585.35 (-0.13%)	33.79	5.82	14.27	28.52	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
73	Gufic Biosciences Ltd.	Q V PT	3,865 Small Cap	391 (1.45%)	61.2	5.82	16.69	24.75	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
74	Glenmark Pharmaceuticals Ltd.	Q V+ PT	61,943 Mid Cap	2,209.85 (0.68%)	45.48	5.89	4.60	14.41	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
75	Jupiter Life Line Hospitals Ltd.	Q V PT	9,528 Small Cap	1,454.85 (0.12%)	49.78	5.93	21.03	54.25	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
76	Healthcare Global Enterprises Ltd.	Q V+ PT	9,664 Small Cap	658.25 (1.70%)	662.8	6.02	13.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
77	Mankind Pharma Ltd.	Q V PT	1,02,729 Mid Cap	2,531.15 (1.76%)	50.42	6.27	14.65	12.79	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
78	Innova Captab Ltd.	Q V PT	5,605 Small Cap	956.50 (-2.34%)	66.97	6.32	25.90	14.68	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
79	Wockhardt Ltd.	Q V+ PT	31,660 Small Cap	1,938.40 (-0.51%)	148.64	6.41	1.15	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
80	Jagsonpal Pharmaceuticals Ltd.	Q V+ PT	1,548 Small Cap	236.05 (0.36%)	35.94	6.52	11.13	39.15	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
81	RPG Life Sciences Ltd.	Q V+ PT	3,958 Small Cap	2,416.65 (0.98%)	34.37	6.54	11.71	30.85	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
82	Concord Biotech Ltd.	Q V PT	13,435 Small Cap	1,280.05 (-0.33%)	51.49	6.66	18.56	18.12	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
83	Supriya Lifescience Ltd.	Q V+ PT	8,004 Small Cap	979.60 (-1.50%)	38.28	6.68	17.45	18.30	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
84	Jubilant Pharmova Ltd.	Q V+ PT	15,492 Small Cap	968.75 (-0.40%)	778.52	6.7	-24.99	-38.93	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
85	Wanbury Ltd.	Q V+ PT	1,002 Small Cap	287.20 (0.12%)	15.15	6.94	10.29	30.27	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
86	Nephrocare Health Services Ltd.	Q V+ PT	6,764 Small Cap	672.20 (-0.29%)	N/A	6.97	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
87	Dr Agarwals Eye Hospital Ltd.	Q V PT	2,468 Small Cap	5,033.05 (-1.43%)	35.2	7.13	17.68	31.54	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
88	Blue Jet Healthcare Ltd.	Q V PT	9,855 Small Cap	554.45 (-2.41%)	39.77	7.25	0.00	0.00	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
89	Marksans Pharma Ltd.	Q V+ PT	12,102 Small Cap	264 (-1.14%)	40.25	7.32	22.06	32.86	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
90	Metropolis Healthcare Ltd.	Q V PT	11,275 Small Cap	555.70 (2.19%)	59.34	7.45	9.22	2.10	Add to Portfolio Add to Watchlist Decision Maker P/E Chart Dividend History
Prev 1 2 3 4 5 Next

Screens:

AlphaCases Top Rated Stocks Best Nifty Stocks Best Nifty Next Stocks Best Nifty 500 Stocks Best SmallCap Stocks Top BFSI Stocks

Pharma - Today's Top Gainers

Company Name	CMP	Price Change(%)
Suven Life Sciences	327.55	9.68%
Shree Ganesh Remed.	673.90	4.90%
Piramal Pharma	175.90	4.58%
Dishman Carbogen Amc	196.60	4.57%
Kopran	194.55	4.07%

Pharma - Today's Top Losers

Company Name	CMP	Price Change(%)
Rubicon Research	1,302.75	-5.22%
IOL Chem & Pharma	143.05	-4.76%
Bliss GVS Pharma	506.15	-3.87%
Poly Medicure	1,680.05	-3.32%
3B Blackbio Dx	1,172.50	-2.92%

News about Top Pharma Companies in India

Jul, 2026

Jubilant Pharmova informs about compliances-certificate

In terms of Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018, Jubilant Pharmova has enclosed a confirmation Certificate for the quarter ended on June 30, 2026 received from Alankit Assignments, Registrar and Share Transfer Agent of the Company.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Glenmark Pharmaceuticals informs about media release

Glenmark Pharmaceuticals has informed that, Glenmark Specialty S.A, a wholly owned subsidiary of the company (Glenmark) announced the advancement of its multi-country Phase 3 clinical trial for Trastuzumab rezetecan (SHR-A1811), a HER2-targeted antibody drug conjugate (ADC), for patients with platinum-resistant ovarian cancer (PROC). India will serve as the first country in Glenmark’s licensed markets to initiate patient enrollment for the Phase 3 clinical trial, following the approval of Drugs Controller General of India (DCGI). Glenmark also plans to enroll patients in Australia and South Korea, subject to regulatory approvals. The company has attached media release.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

Mankind Pharma informs about press release

Mankind Pharma has informed that it enclosed copies of the newspaper advertisement published in ‘Financial Express’ (English) and ‘Jansatta’ (Hindi) on July 1, 2026 regarding 35th Annual General Meeting of the Company scheduled to be held on Tuesday, August 4, 2026 at 03:30 PM (IST) through Video Conferencing / Other AudioVisual Means.

The above information is a part of company’s filings submitted to BSE.

Jul, 2026

USFDA completes GMP inspection at Glenmark Pharmaceuticals’ Goa facility

At the end of the inspection, the company was issued a Form 483 with six observations

Jul, 2026

Mankind Pharma submits AGM notice

Mankind Pharma has informed that the 35th Annual General Meeting (AGM) of the Members of Mankind Pharma (the Company) is scheduled to be held on Tuesday, August 4, 2026 at 03:30 pm (IST) through Video Conferencing/ Other Audio-Visual Means in compliance with the applicable provisions of the Companies Act, 2013 (the Act) and the relevant circulars issued by the Ministry of Corporate Affairs and the Securities and Exchange Board of India. Notice of the AGM along with Annual Report for the financial year 2025-26 will be dispatched to the Members in due course in compliance with the applicable provisions of the Act, relevant circulars and Listing Regulations. Above information shall also be available on the website of the Company, www.mankindpharma.com.

The above information is a part of company’s filings submitted to BSE.

Jun, 2026

Vimta Labs informs about closure of trading window

Vimta Labs has informed that as per the provisions of the Company’s code of conduct for prevention of Insider Trading, the Trading Window for transactions in shares of the Company for all designated persons, their immediate relatives and all connected persons under the code will remain closed from 1stJuly 2026 till 48 hours post declaration of unaudited financial results of the Company for the first quarter ended 30th June 2026.

The above information is a part of company’s filings submitted to BSE.

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Rank	Company	Market Capitalization 2026 (INR crores)
1	KMC Speciality Hospitals (India) Ltd.	2,179 Crore
2	Nectar Lifesciences Ltd.	230 Crore
3	Dishman Carbogen Amcis Ltd.	2,948 Crore
4	Unichem Laboratories Ltd.	3,263 Crore
5	Shalby Ltd.	1,873 Crore
6	Lincoln Pharmaceuticals Ltd.	1,253 Crore
7	Natco Pharma Ltd.	16,725 Crore
8	Fabtech Technologies Ltd.	719 Crore
9	Sigachi Industries Ltd.	879 Crore
10	Krsnaa Diagnostics Ltd.	1,857 Crore

Do you know? Asking 3 Right Questions minimizes the RISK of Stock Investing To Know

Right Stock | Right Price | Right Allocation

Find best stocks to buy now Find best pharma stocks to buy now

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

You can use different criterias to arrive at the list of best stocks in the Nifty Pharma company index. You can use return ratios like ROCE or ROE, that will help you choose companies with profitable growth.

Based on ROE, the best stocks in the Nifty Pharma companies index are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	ROE
Abbott India Ltd. (M)	Very Good	25,850	54,657	35.22	11.45	24.04	35.71
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,57,804	72.94	18.81	38.40	29.04
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,776	39.56	9.23	26.73	25.35
Lupin Ltd. (M)	Somewhat Good	2,476	1,09,676	20.57	4.89	11.90	20.83
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,09,691	21.76	4.22	13.36	20.74

Based on the past year's gain, the best performing stocks are:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	Yearly gain (%)
Laurus Labs Ltd. (M)	Very Good	1,542	82,399	103
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,225	44.17
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,57,804	42.84
Aurobindo Pharma Ltd. (M)	Very Good	1,620	89,762	40.20
Gland Pharma Ltd. (S)	Very Good	2,461	40,341	31.30
				View More

Stocks with the highest revenue growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Sales Growth (%)
JB Chemicals & Pharmaceuticals Ltd. (S)	Very Good	2,363	37,225	55.22	9.22	33.44	15.51
Mankind Pharma Ltd. (M)	Very Good	2,531	1,02,729	50.42	6.27	31.67	14.65
Ajanta Pharma Ltd. (M)	Very Good	3,326	41,776	39.56	9.23	26.73	13.54
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,12,368	26.78	2.98	14.95	12.09
Torrent Pharmaceuticals Ltd. (L)	Very Good	4,766	1,57,804	72.94	18.81	38.40	11.80

Stocks with high profit growth often witness their stock prices gaining, irrespective of the market movements.

Stocks with the highest profit growth in the past 5 years is:

Company Name	Is it a Right Stock ?	CMP	Market Cap(Cr.)	P/E	P/BV	EV/EBITDA	5Y Profit Growth (%)
Zydus Lifesciences Ltd. (M)	Very Good	1,141	1,09,691	21.76	4.22	13.36	30.57
Sun Pharmaceutical Industries Ltd. (L)	Very Good	1,905	4,49,048	39.12	5.37	22.41	23.50
Abbott India Ltd. (M)	Very Good	25,850	54,657	35.22	11.45	24.04	18.78
Dr. Reddys Laboratories Ltd. (M)	Very Good	1,375	1,12,368	26.78	2.98	14.95	15.75
Glenmark Pharmaceuticals Ltd. (M)	Very Good	2,210	61,943	45.48	5.89	12.07	14.41

You have 9 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login | Register Now

Create stable, long-term investment portfolio with strong, consistent stocks.

Start Research-backed Investing ...Now. Subscribe to Sapphire

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Fiduciary-first advisory model.
As SEBI-registered IAs, we are legally and ethically bound to act in the best interests of our clients. We do not sell or distribute any financial products. This ensures our guidance is 100% unbiased and conflict-free.
Deep fundamental research + robust valuation discipline.
Built on more than 15 years of equity research, our framework combines quality assessment, intrinsic value estimation, and a sensible margin-of-safety approach.
Process—not predictions.
We don’t rely on guesswork or market timing. Instead, we focus on asset allocation, risk management, and long-term compounding.
Technology + Human Intelligence.
We believe a combination of both is essential for investing success. We constantly innovate and upgrade in-house tools, financial X-rays, and portfolio analytics so that our team of analysts and advisors are equipped with the best.
Partner with Clients.
We follow a DIWM (Do-It-With-Me) approach where we partner clients in setting goals, financial planning, educating on our investing process and share decision-enabling resources transparently with our clients who retain control on execution.

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

Investing in stocks, mutual funds, debt, and gold
Quality-at-Reasonable-Price way of investing in stocks
Constructing Direct Stock Portfolios with Core, Booster, and Amplifier stocks
A Mutual Fund Portfolio that delivers consistent out-performance and meaningful diversification (low overlap)
Periodic review and rebalancing
Clear Buy-Sell-Hold, and Position-sizing frameworks

Name of the IA registered with SEBI:	The Alchemists Ark Pvt. Ltd.
Logo:
Trade/Brand Name of IA:	MoneyWorks4Me Investment Advisers
Brand Logo:
SEBI Registration Number:	INA000013323 Validity – May 16, 2019 – Perpetual
Registration:	Non-Individual
BSE Enlistment No:	1187
Address:	B-101, Signet Corner Building, Balewadi Phata, Baner, Pune, Maharashtra 411045
Compliance officer Details:	Name: Shrikant Jagtap Email: shrikant.jagtap@moneyworks4me.com Telephone: +919860359463 Address: Same as IA
Grievance Officer Details:	Name: Mukta Vaze Email: mukta.vaze@moneyworks4me.com Telephone: +91 98609 19463 Address: Same as IA
Principal Officer Details:	Name: Atharva Bhide Email: atharva.bhide@moneyworks4me.com Telephone: +91 91758 99463 Address: Same as IA
Standard Warning:	Investment in securities market are subject to market risks. Read all the related documents carefully before investing.
Disclaimer:	Registration granted by SEBI, enlistment with exchange and certification from NISM in no way guarantee performance of the intermediary or provide any assurance of returns to investors.

Top Pharma Companies in India by Market Cap

News about Top Pharma Companies in India

Jubilant Pharmova informs about compliances-certificate

Glenmark Pharmaceuticals informs about media release

Mankind Pharma informs about press release

USFDA completes GMP inspection at Glenmark Pharmaceuticals’ Goa facility

Mankind Pharma submits AGM notice

Vimta Labs informs about closure of trading window

Publicly traded pharmaceuticals

Top 10 Publicly Listed pharmaceutical stocks in India by Market Capitalization as of 2026.

Top 15 Pharma Stocks by Revenue Growth

Top Pharma Companies Source: NSE Indices

How to select the top Nifty Pharma stocks based on RoE?

What are the best-performing stocks in the Nifty Pharma index?

Which Nifty Pharma stocks have the highest revenue growth in the past five years?

Which Nifty Pharma stocks had the highest profit growth in the past five years ?

Create stable, long-term investment portfolio with strong, consistent stocks.

About MoneyWorks4Me

Our Vision

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.